Trials / Completed
CompletedNCT01367652
Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fasted Conditions
A Single Dose, 2-Period, 2-Treatment 2-Way Crossover Bioequivalency Study of Letrozole Tablets Under Fasted Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Roxane Laboratories · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study was to prove the bioequivalence of Letrozole Tablet under fasted conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Letrozole | 2.5 mg tablet |
| DRUG | Letrozole | 2.5 mg Tablet |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2008-04-01
- Completion
- 2008-04-01
- First posted
- 2011-06-07
- Last updated
- 2018-01-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01367652. Inclusion in this directory is not an endorsement.